StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Depomed (DEPO): Challenging Opioid Environment Continues To Weigh On Results - RBC
August 8, 2017 6:34 AM
RBC Capital analyst, Randall Stanicky, reiterated his Sector Perform rating on shares of DepoMed Inc (NASDAQ: DEPO) and cut his ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Morgan Stanley Downgrades DepoMed Inc (DEPO) to Underweight
August 8, 2017 8:42 AM
DepoMed Inc (DEPO) PT Lowered to $9 at Piper Jaffray
August 8, 2017 8:23 AM